Target intelligence / Profile preview

Ribosomal protein L7-like 1 pseudogene 4 (RPL7L1P4)

Target
RPL7L1P4
Molecular classification
Other
01

Overview

Ribosomal protein L7-like 1 pseudogene 4 (RPL7L1P4) is a pseudogene derived from the ribosomal protein L7-like 1 (RPL7L1) gene. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they generally do not encode functional proteins and usually do not have biological roles or disease associations attributed to active protein-coding genes. Consequently, RPL7L1P4 is not considered a therapeutic target and no known drugs, biomarkers, or safety concerns are associated. The functional ribosomal protein L7-like 1 gene (RPL7L1) itself is sometimes studied in cancer, but the pseudogene variant (RPL7L1P4) lacks evidence of independent function or clinical relevance[5][1][2][3]. Key points: - RPL7L1P4 is a pseudogene, not an active protein-coding gene. - Not recognized as a drug target, biomarker, or disease gene. - Some database records (and commercial suppliers) include this entry for completeness, but it should not be confused with the protein-coding gene RPL7L1[5][1][2][3]. - Therefore, this is an incorrect target for therapeutic or biomarker applications.

Other names
RPL7L1P4ribosomal protein L7-like 1 pseudogene 4Rpl7l1-ps4

Beyond the preview

Go deeper on Ribosomal protein L7-like 1 pseudogene 4 (RPL7L1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7-like 1 pseudogene 4 (RPL7L1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call